Hemispherx, Bioclones join up on cancer vax; ClearPath appoints new CMO;

> Hemispherx and South Africa's Bioclones have joined forces on a therapeutic cancer vaccine. Release

> ClearPath Vaccines Company has brought on Donna Ambrosino as its chief medical officer. Release

> The CDC temporarily closed its anthrax and flu labs after back-to-back accidents. More (sub. req.)

> The National Institutes of Health (NIH) has awarded GeoVax with its Small Business Innovative Research grant. Release

And Finally... A cargo of anthrax vaccine that sank in a Siberian river has been recovered, officials say. Report

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

As a new coronavirus spreads, vaccine researchers have started work on candidates against the virus—and one could enter the clinic in a few months.

Merck's HPV vaccine Gardasil is delivering blockbuster sales as demand surges. But high demand has caused somewhat of a supply constraint.